Next Article in Journal
Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
Previous Article in Journal
Function of Adenylyl Cyclase in Heart: the AKAP Connection
Article Menu

Export Article

Open AccessFeature PaperReview
J. Cardiovasc. Dev. Dis. 2018, 5(1), 3; https://doi.org/10.3390/jcdd5010003

Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal

CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
Running Head: Treatment Applied in Portugal of Pre-Eclampsia.
*
Author to whom correspondence should be addressed.
Received: 11 December 2017 / Revised: 9 January 2018 / Accepted: 14 January 2018 / Published: 17 January 2018
View Full-Text   |   Download PDF [814 KB, uploaded 17 January 2018]   |  

Abstract

Pre-eclampsia and eclampsia are two hypertensive disorders of pregnancy, considered major causes of maternal and perinatal death worldwide. Pre-eclampsia is a multisystemic disease characterized by the development of hypertension after 20 weeks of gestation, with the presence of proteinuria or, in its absence, of signs or symptoms indicative of target organ injury. Eclampsia represents the consequence of brain injuries caused by pre-eclampsia. The correct diagnosis and classification of the disease are essential, since the therapies for the mild and severe forms of pre-eclampsia are different. Thus, this review aims to describe the most advisable antepartum pharmacotherapy for pre-eclampsia and eclampsia applied in Portugal and based on several national and international available guidelines. Slow-release nifedipine is the most recommended drug for mild pre-eclampsia, and labetalol is the drug of choice for the severe form of the disease. Magnesium sulfate is used to prevent seizures caused by eclampsia. Corticosteroids are used for fetal lung maturation. Overall, the pharmacological prevention of these diseases is limited to low-dose aspirin, so it is important to establish the safest and most effective available treatment. View Full-Text
Keywords: pre-eclampsia; eclampsia; pharmacological therapy; pathophysiology; Portugal pre-eclampsia; eclampsia; pharmacological therapy; pathophysiology; Portugal
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Peres, G.M.; Mariana, M.; Cairrão, E. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. J. Cardiovasc. Dev. Dis. 2018, 5, 3.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Cardiovasc. Dev. Dis. EISSN 2308-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top